Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.

Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...

Medtech manufacturers gathered in Amsterdam to discuss the latest innovations for managing diabetes. Here are three highlights from the first day of the conference: 1. Dexcom previews new data for ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-regio ...